Note:
I have covered Amyris (NASDAQ:AMRS) previously, so investors should view this as an update to my earlier articles on the company.
Emerging specialty renewable products developer Amyris reported Q3/2019 results last week and announced the refinancing of its toxic convertible notes which the company had defaulted on two months ago.
Picture: Selection of Pipette products, the company's new baby skincare brand - Source: Company Press Release
While product revenues resembled their upward trajectory going into the important Q4 holiday season after three quarters of roughly flat sales, the 43.8% sequential increase came